Biotech Analysts Agrawal, Chen & Watsek, along with Dr. Smith, Director of Genitourinary Malignancies Program at Massachusetts General Hospital, discuss novel therapies in prostate cancer on an Analyst/Industry conference call to be held on January 29 at 12 pm. Webcast Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EXEL:
- Exelixis announces results of study evaluating cabozantinib in mCRPC treatment
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Bristol Myers, Exelixis announce four-year results from Opdivo-Cabometyx trial
- EPO rules in favor of Exelixis on patent covering Cabometyx
- Biotech Alert: Searches spiking for these stocks today